Yamamoto Y, Yamashiro H, Toh U, Kondo N, et al. Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study. Breast Cancer 2020 Jul 26. pii: 10.1007/s12282-020-01138.
PMID: 32715420